Design and Characterization of Orodispersible Tablet of Ketorolac Tromethamine RESULT AND DISCUSSION Ketorolac Tromethamine is a potent NSAID agent with moderate bioavailability with highly bitter in taste. We have found that MDT technology will be better to improve bioavailability and taste masking of the selected drug. MDT tablet will releases their contents rapidly for immediate onset of action, to prevent its first pass metabolism, and to improve bioavailability. It also leads to reduction of dose and drug toxicity, which lead to improve patient compliance The solubility of Ketorolac tromethamine was determined in different solvent systems and buffers The IR spectra of physical mixture of polymers and drug were shown in Figure 4.8. …show more content…
The infrared absorption spectra of pure polymer and physical mixture of polymer and drug were run and between 4000 cm-1-500 cm-1 . Result and Discussion 91 Ketorolac tromethamine mouth dissolving tablet Melting point-166.6 between 165 and1 70 with decomposition and contain protein binding 99.2% For the determination of partition coefficient of human insulin, n-octanol was used as oil phase and phosphate buffer pH 7.4 was used as aqueous phase. Phosphate buffer saline pH 7.4 and n-octanol 0.64 The absorption maxima (λmax) of ketorolac tromethamine (5 µg/ml) in this solution was found to be 372 nm which is concordant with the Indian Pharmacopoeia …show more content…
Prior to the formulation, preformulation study was carried out on drug and excipients, in the present work, formulation part divided in to four steps. In first step, preparation of preparation of dummy tablets were done by using different such as lactose monohydrate , Mannitol, microcrystalline cellulose and its combination in different ratio . The detailed composition is shown in table . The dummy tablets were also evaluated for various physical parameters such as thickness, hardness, friability, weight variations, and disintegration. The powder blends were subjected to evaluation such as angle of repose, bulk density, tapped density, % compressibility and Hausner ratio. The tablet parameters (effect of diluents on tablet) were found to be shown in table form these matrix combinations of lactose and microcrystalline cellulose were selected for further tablet
Torsades de pointes in amiodarone-associated acquired long-QT syndrome Amiodarone was developed in Belgium in 1961 and became popular in Europe for the treatment of angina. Based on Dr. Bramah Singh's investigation, (1) the Argentine physician Dr. Mauricio Rosenbaum started using amiodarone for the treatment of ventricular and supraventricular arrhythmias with good outcomes. (2, 3) This drug is a class III agent in the Vaughan Williams scheme, with class I. II and IV antiarrhytmic effects.
Therefore, liquid-liquid and acid-base extraction techniques were successfully performed to separate the components of the Excedrin tablet. According to the TLC analysis results, the compounds (aspirin, acetaminophen, and caffeine) were successfully isolated from the analgesic (Excedrin tablet). In figure 1, the separation of the compound in the TLC analysis correlates with the TLC analysis in figure 2. Furthermore, Rf index calculations of the TLC analysis demonstrated that the compounds (aspirin, acetaminophen, and caffeine) were separated. The Rf calculations of aspirin in table 1 shows an Rf value of .491; however, in table 2 the Rf value of aspirin was calculated to be .784.
The difference in this chemical and physical properties will aid in their separation. Processes like solubility, gravitational filtration and recrystallization will be used to separate the substances present in Panacetin. The melting and boiling point of the substances will help in concluding on which of these compounds will be presented at the end of experiment. Procedure and observation The Panacetin content was weighed approximately 3.0493g and transferred to the Erlenmeyer flask; 75ml of dichloromethane (CH¬2CL2) was added to the content. The dichloromethane (CH2Cl2) dissolved the sucrose, leaving the active unknown agent and aspirin behind.
Percocet Withdrawal Treatment Percocet is a combination of acetaminophen and oxycodone. Acetaminophen is a pain reliever which is less potent but its effect increased when it is combined with oxycodone. Oxycodone is an opioid pain medication. Percocet is often used as a prescription drug to relieve moderate to severe pain. But too much of Percocet dependency leads to addiction of it.
As respiratory therapist we will have the ability to deliver three types of bronchodilators depending on symptoms the patient is displaying or as a maintenance drug in diseases like COPD, emphysema and cystic fibrosis. It is vital that we know which medication works best in each circumstance. Beta-agonists are medications that use the beta-2 receptors in our airway in order to help smooth muscle relaxation and bronchodilation. The beta-agonists primarily affect the bronchioles (small airways). These medications are usually given by inhalations, pills, tablets and intravenously, but most frequently by inhalation due to less side-effects.
What Is Cognishield? Cognishield is a type of nootropic supplement. It works by enhancing concentration, memory and brain function. Nootropics are often referred to as smart pills, brain enhancers or neuroenhancers. There are conditions that have to be met in order for a supplement to be classified as a nootropic.
Introduction The isolation of an active ingredient in analgesic drugs is an important technique to determine a drug’s composition. This technique can be exercised through column chromatography, a method used to purify a specific compound in a mixture. In column chromatography, alumina is typically used to separate less polar compounds by acting as a purifying agent. Most analgesic drugs work as pain relievers and generally fall into four categories.
Objectives The objective of this experiment is to perform Quality Control (QC) tests to assess if the Acetaminophen sample prepared by previous polytechnic students during their internship is in compliance with the monograph in the British Pharmacopoeia (BP). There were 3 different samples prepared A, B, and C. My group and I performed the experiments using sample B. For drugs to be deemed suitable for public consumption they must meet certain criteria to ensure that they will not cause more harm than good. Furthermore, we must be certain that the quality of these drugs is consistent.
The following lab period the solid was weighed (0.0483 g) and percent yield was calculated (65.5%) with the limiting reagent being tetraphenylcyclopentadienone. The melting point was determined. The first melting point was 204-204.9 °C and the second melting point was 215.6-215.9°C. Finally, an infrared spectroscopy was obtained for the
PHARMACOLOGY OF DEXMEDETOMIDINE Dexmedetomidine HCl, an imidazole compound is the pharmacologically active s-enantiomer of medetomidine, a veterinary anaesthetic agent. It is described chemically as (+)-4-(s)[2 3 –(dimethylphenyl) ethyl]-11 H-imidazole monohyrochloride. Its empirical formula is C13H16N2HCl and its molecular weight is 236.7(57). Figure 4 : Structure of Dexmedetomidine PHYSIOCHEMICAL PROPERTIES A white or almost white powder that is freely soluble in water with Pka of 7.1.Partition coefficient in octanol: water at pH 7.4 is 2.89.
Based on the assumed contamination of the TLC plate and or capillary tube, it is not possible to tell whether acetaminophen was successfully separated from the Excedrin powder. The Rf values of isolated aspirin and pure aspirin were the same. This demonstrates that the aspirin was successfully separated and is relatively pure. The isolated caffeine sample had a higher Rf value but when viewed under UV light, the markings of isolated caffeine were within the bounds of the pure caffeine, leading to the conclusion that while isolated the caffeine sample was note
A UV spectrum of drotaverine hydrochloride, ethamsylate, tranexamic acid in water was noted by scanning the solution in the range of 200-400nm. drotaverine hydrochloride, ethamsylate, tranexamic acid was showing significant absorption at 220nm. thus that was selected as wavelength for analysis. Preparation of standard stock solution
After that, she was suggested with the extended-release and transdermal formulation of oxybutynin. If we compare the immediate release and extended release formulation of oxybutynin, extended-release was chosen in order to help Mrs Miller. This is because extended-release formulation is more tolerability than immediate release. It can lower the side effect that has been experienced by Mrs Miller. For the immediate release formulation, it will undergo extensive upper gastrointestinal first pass metabolism.
The results displayed in Table 1 provide the weights of unknown D prior to filtration and after crystallization. Due to the fact that the starting product of this experiment was an impure substance of acetyl salicylic acid, it weighed more than the purified end result, or crystals. This was due to the impurities included in the starting product. The impurities in the solid form were filtered out of the solution through the column with methanol. These impurities could potentially include active pharmaceutical ingredients and other ingredients such as a binder to keep the tablet from falling apart, or a coating to facilitate swallowing, and also colorants.
INTRODUCTION This assignment is about the study of the effect of agonist and different concentration on guinea pig ileum and it will consist of method, graph results and discussion. Drug is defined as a chemical that has both biological and pharmacological effects on human. Its branch is pharmacology which can be divided into two branches namely pharmacodynamics and pharmaco kinetics. (C. Stephen and W. Robin (2010)) Pharmaco dynamic is about what drug does to the body and pharmaco kinetics is the study of what the body does to the drug.